Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CD44 | P16070 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28424985 | 0.82 | PDCD1 (0.37) | TSHRALDH1A1 | |
| SCHEMBL22171381 | 0.80 | TP53 (0.31) | SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL29213071 | 0.78 | ALDH1A1 (0.31) | CYP3A4ALDH1A1SMN1; SMN2 | |
| SCHEMBL28331283 | 0.73 | CD44 (0.34) | ALDH1A1CD44 | |
| SCHEMBL30879937 | 0.73 | ALDH1A1 (0.36) | CYP3A4TSHRALDH1A1SMN1; SMN2 | |
| SCHEMBL28014936 | 0.71 | ALDH1A1 (0.40) | CYP3A4ALDH1A1SMN1; SMN2 | |
| SCHEMBL1153470 | 0.70 | MAOA (0.33) | — | |
| SCHEMBL30839749 | 0.68 | CYP3A4 (0.72) | CYP3A4TSHRPIK3CAALDH1A1HPGD | |
| SCHEMBL2206282 | 0.68 | CYP3A4 (0.72) | CYP3A4TSHRPIK3CAALDH1A1HPGD | |
| SCHEMBL23966394 | 0.67 | CYP3A4 (0.42) | CYP3A4TSHRPIK3CAALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2010-04-08 | — | — | US | disclosed |
| EP-1914221-A1 | PROCESS FOR PRODUCING BIARYL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2008-04-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | NISCH, BLVRB, BBOX1 | CYP3A4 177/4885TSHR 1688/4885PIK3CA 2327/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.